Logo

American Heart Association

  13
  0


Final ID: Su2173

Heart Failure with Preserved Global Longitudinal Strain: A Distinct Phenotype in Patients with Preserved Ejection Fraction: Data from A Real-World Registry

Abstract Body (Do not enter title and authors here): Background: Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome caused by various pathophysiologic mechanisms, and has recently received increasing attention. Many research results show that the longitudinal left ventricular (LV) function is deteriorated, however, in the real world, we often encounter patients with preserved LV global longitudinal strain (GLS). This study sought to determine the prevalence, characteristics, and outcome of patients with preserved LV GLS in a real-world registry of HFpEF.
Method: The registry data included 1,798 patients with HFpEF (72.2 ± 11.6 years, 55.2% female) who met the inclusion criteria of previous randomized controlled trials (New York Heart Association class II or higher symptoms, LVEF > 40%, and NT-proBNP > 300 pg/mL) at a single tertiary hospital between 2014 and 2021. LV GLS analysis was performed using vendor-independent 2D speckle-tracking imaging software (TomTec; Image Arena 4.6, Munich, Germany). Patients with LV GLS ≤ -18% were defined as heart failure with preserved GLS. The primary outcome was a composite of heart failure admissions and cardiovascular death.
Results: In this population, 757 (42.1%) patients had preserved LV GLS. The patients with preserved GLS were tended to be younger (71.7 ± 11.5 vs. 72.7 ± 11.6 years, p=0.073) and more female predominance (60.6 vs. 51.3%, p<0.001), and wider pulse pressure (61.0 ± 17.4 vs. 54.8 ± 18.1 mmHg, p<0.001) compared with those with reduced GLS. The average NT-pro BNP of the preserved GLS group was 2242.4 ± 4391.8 pg/ml and the average LV GLS was -20.1±1.6%, which were significantly lower than each value of the reduced GLS group. In terms of echocardiographic characteristics, the patients with preserved GLS had higher LV ejection fraction (68.8 ± 5.8 vs. 62.5 ± 8.6%, p<0.001) and stroke volume (78.1 ± 21.4 vs. 61.9 ± 19.3, p<0.001). During 21.3 months (interquartile range 6.6-39.7 months) follow-up, the group with preserved GLS had a better primary outcome than the group with reduced GLS (log-rank p < 0.001) (Figure)
Conclusion: Heart failure with preserved GLS is common among patients with HFpEF in real-world data. This phenotype is more common in females, is associated with higher stroke volume and arterial stiffness, and ultimately shows a favorable outcome.
  • Kim, Gi Rim  ( Severance Cardiovascular Hospital, Yonsei University College of Medicine , Seoul , Korea (the Republic of) )
  • Kim, Kyu  ( Severance Cardiovascular Hospital, Yonsei University College of Medicine , Seoul , Korea (the Republic of) )
  • Gwak, Seo-yeon  ( Severance Cardiovascular Hospital, Yonsei University College of Medicine , Seoul , Korea (the Republic of) )
  • Lee, Hyun-jung  ( Severance Cardiovascular Hospital, Yonsei University College of Medicine , Seoul , Korea (the Republic of) )
  • Cho, Iksung  ( Severance Cardiovascular Hospital, Yonsei University College of Medicine , Seoul , Korea (the Republic of) )
  • Hong, Geu-ru  ( Severance Cardiovascular Hospital, Yonsei University College of Medicine , Seoul , Korea (the Republic of) )
  • Ha, Jong-won  ( Severance Cardiovascular Hospital, Yonsei University College of Medicine , Seoul , Korea (the Republic of) )
  • Shim, Chi Young  ( Severance Cardiovascular Hospital, Yonsei University College of Medicine , Seoul , Korea (the Republic of) )
  • Author Disclosures:
    Gi Rim Kim: DO NOT have relevant financial relationships | Kyu Kim: DO NOT have relevant financial relationships | Seo-Yeon Gwak: No Answer | Hyun-Jung Lee: No Answer | Iksung Cho: DO NOT have relevant financial relationships | Geu-Ru Hong: DO NOT have relevant financial relationships | Jong-Won Ha: DO NOT have relevant financial relationships | Chi Young Shim: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Frontiers in HFpEF Part 1: Echocardiography and Hemodynamic Findings

Sunday, 11/17/2024 , 11:30AM - 12:30PM

Abstract Poster Session

More abstracts on this topic:
Abatacept Drug-Induced Loeffler Endocarditis: A Manifestation of Hypereosinophilic Syndrome

Sweeting Alexander, Atalay Michael, Agarwal Saurabh, Hulten Edward, Patel Yash

Different Determinants of Thrombotic Events in Transthyretin Cardiac Amyloidosis versus Other Left Ventricular Hypertrophy Phenotypes

Ozbay Benay, Rearick Corey, Satyavolu Bharadwaj, Soman Prem, Wong Timothy, Azhar Abdullah, Katz William, Sade Leyla Elif

More abstracts from these authors:
Predictors of progression to left ventricular systolic dysfunction in hypertrophic cardiomyopathy patients with borderline left ventricular systolic function

Lee Hyun-jung, Park Sang-shin, Galimkhan Nurjanar, Gwak Seo-yeon, Kim Kyu, Cho Iksung, Shim Chi Young, Ha Jong-won, Hong Geu-ru

VEIN-SCORE: a new risk score for chronic venous insufficiency in patients who experienced leg swelling

Shim Chi Young, Kim Kyu, Lee Hyun-jung, Cho Iksung, Hong Geu-ru, Ha Jong-won

You have to be authorized to contact abstract author. Please, Login
Not Available